サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575809

リゾレシチンの世界市場：2024年～2031年

Global Lysolecithin Market - 2024-2031

出版日
ページ情報
英文 215 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
リゾレシチンの世界市場：2024年～2031年
出版日: 2024年10月22日
発行: DataM Intelligence
ページ情報: 英文 215 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

リゾレシチンの世界市場は、2023年に1億5,750万米ドルに達し、2031年には2億8,430万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは7.7%で成長する見込みです。

リゾレシチンは、ミセルやリポソームを形成する能力を含むユニークな特性を持っており、ドラッグデリバリーシステムの有望な選択肢となっています。研究者らは、バイオアベイラビリティと治療効果を高めることを意図して、様々な医薬品有効成分をカプセル化して輸送するリゾレシチンの可能性を調査しています。

さらに、業界の主要企業が革新的な製品を発売しており、これが市場成長の原動力となっています。例えば、Kemin Industries, Inc.は、リゾリン脂質由来の栄養乳化剤LYSOFORTEを発表しました。この製品は、家畜や家禽の飼料に含まれる油脂や脂溶性栄養素など、エネルギー密度の高い飼料成分の消化吸収を促進するよう特別に設計されています。その革新的な配合は、脂肪消化に不可欠な3つの段階（乳化、加水分解、吸収）を最適化します。

ダイナミクス

健康効果に対する消費者の意識の高まり

世界のリゾレシチン市場の需要は、複数の要因によって牽引されています。重要な要因のひとつは、健康効果に対する消費者の意識の高まりです。リゾレシチンの健康効果に対する消費者の意識は、特に世界市場において、複数の部門にわたる様々な製品へのリゾレシチンの組み込みに大きな影響を与えています。研究によると、リゾレシチンは脳の健康と認知機能を改善する可能性があり、特に高齢化した集団の中で、精神の明晰さと記憶力を高めたい消費者にとって魅力的です。

天然成分や非遺伝子組み換え成分への嗜好の高まりにより、リゾレシチンはクリーンラベル製品に好まれる選択肢となっています。健康志向の消費者は、自分の食生活に合った身近な原材料を使った商品をますます求めるようになっています。リゾレシチンの適応性は、飲食品、栄養補助食品、パーソナルケアなど、様々な分野の製品への配合を可能にしています。

バイオテクノロジーとライフサイエンスにおける継続的な進歩と革新は、特に医療と健康関連製品の分野において、リゾレシチンの使用に新たな機会を生み出しています。消費者の健康志向が高まるにつれ、機能性食品や栄養補助食品に対する需要が大幅に増加しています。

さらに、業界の主な企業は、この市場の成長を促進するような製品の発売や主要な開発を行っています。例えば、日光ケミカルズは2023年8月、セラミドとフィラグリンの産生を刺激することで皮膚のバリア機能を高めることを目的とした製品「ニッコールレシノールMFL」を発売しました。表皮細胞への幅広い作用で知られるリゾレシチンの一種、リゾホスファチジン酸を豊富に含みます。

増加する医薬品製剤

医薬品開発が進むにつれ、リゾレシチンは乳化剤、可溶化剤、安定剤としての特性を持ち、ドラッグデリバリーシステムの有効性を高める上で重要な役割を果たすことから人気を集めています。製薬業界は、バイオアベイラビリティの向上、放出制御、有効成分の吸収促進を必要とする新しい製剤を常に開発しています。

天然のリン脂質であるリゾレシチンは、疎水性薬物の溶解性を向上させるために使用され、様々な薬物製剤において好ましい選択肢となっています。リポソームを形成し、エマルションを安定化させるリゾレシチンの能力は、薬剤のデリバリーと吸収を促進し、これは経口剤、外用剤、注射剤の用途において特に重要です。

医薬品市場において、より複雑な製剤の需要が高まるにつれ、リゾレシチンのような機能性成分のニーズが高まっています。さらに、特殊なドラッグデリバリーシステムを伴うことが多い個別化医療の動向は、市場におけるリゾレシチンの使用を後押しすると予想されます。製薬会社は、より効果的で患者に優しい医薬品を作るためにリゾレシチンを活用し、それによって世界のリゾレシチン市場の成長を促進しています。

より安価な合成乳化剤の入手可能性

ポリソルベート、モノグリセリド、ジグリセリドなどの合成乳化剤は、リゾレシチンのような天然代替品に比べて低コストで広く入手可能です。これらの合成乳化剤は、食品、化粧品、医薬品において、食感、安定性、保存性の向上など、同様の機能的利点をもたらすことが多いです。その結果、コスト削減を目指すメーカーは、特に加工食品や大衆向けパーソナルケア製品のような価格に敏感な市場では、リゾレシチンよりもこうした低価格の選択肢を選ぶ傾向にあります。

さらに、合成乳化剤の生産はよりスケーラブルで、天然リゾレシチンの入手可能性や価格にしばしば影響を与える農業サプライチェーンの影響を受けにくい傾向にあります。合成乳化剤は安定した品質と量で生産できるため、天然乳化剤よりも有利であり、市場における合成乳化剤の地位をさらに強固なものにしています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 健康効果に対する消費者の意識の高まり
      • 製剤数の増加
    • 抑制要因
      • より安価な合成乳化剤の入手可能性
    • 機会
    • 影響分析

第5章 業界分析

  • ポーターのファイブフォース分析
  • 規制分析
  • 価格分析
  • 特許分析
  • SWOT分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 輸出入分析
  • 臨床試験分析
  • 消費者分析
  • 持続可能性分析
  • ヒートマップ
  • B2B分析

第6章 供給源別

  • 植物
    • 大豆
    • ひまわり
    • 菜種（キャノーラ）
  • 動物
    • モルモット
    • ウシ

第7章 タイプ別

  • 加水分解リゾレシチン
    • 加水分解液
    • 脱油加水分解物
  • 化学修飾リゾレシチン
  • その他

第8章 形状別

  • 粉末
  • 液体
  • 顆粒

第9章 用途別

  • 菓子類
  • ベーカリー
  • 食品サプリメント
  • 動物飼料
  • 乳製品
  • パーソナルケアと化粧品
  • 植物ベースの代替品
  • その他

第10章 エンドユーザー別

  • 飲食品
  • 医薬品
  • 化粧品
  • 栄養補助食品

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Kemin Industries, Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Cargill, Inc.
  • Lipoid GmbH
  • Sternchemie GmbH & Co. KG
  • Alexmo Cosmetics
  • Cayman Chemical
  • Creative Biolabs
  • GlpBio Technology
  • Larodan AB
  • Biosynth Ltd

第14章 付録

目次
Product Code: FB8686

Overview

The Global Lysolecithin Market reached US$ 157.5 million in 2023 and is expected to reach US$ 284.3 million by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.

Lysolecithin possesses unique characteristics, including its capacity to form micelles and liposomes, which make it a promising option for drug delivery systems. Researchers are investigating the potential of lysolecithin to encapsulate and transport various active pharmaceutical ingredients, intending to enhance their bioavailability and therapeutic effectiveness.

Further, key players in the industry launching innovative products that would drive this market growth. For instance, Kemin Industries, Inc. introduced LYSOFORTE a nutritional emulsifier derived from lysophospholipids, specifically designed to enhance the digestion and absorption of energy-dense feed components such as fats, oils and fat-soluble nutrients in livestock and poultry diets. Its innovative formulation optimizes three essential stages of fat digestion: emulsification, hydrolysis and absorption.

Dynamics

Rising Consumer Awareness of Health Benefits

The demand for the global lysolecithin market is driven by multiple factors. One of the key factors is the rising consumer awareness of health benefits. Consumer awareness of lysolecithin's health benefits is significantly influencing its incorporation into various products across multiple sectors, particularly in the global market. Studies indicate that lysolecithin may improve brain health and cognitive function, making it appealing to consumers who want to boost mental clarity and memory, particularly within aging populations.

The growing preference for natural and non-GMO ingredients has made lysolecithin a favored option in clean-label products. Health-conscious consumers are increasingly looking for items with familiar ingredients that match their dietary choices. Lysolecithin's adaptability enables its incorporation into a wide variety of products across several sectors, including food and beverages, nutraceuticals and personal care.

Ongoing advancements and innovations in biotechnology and life sciences are creating new opportunities for the use of lysolecithin, especially in the areas of medicine and health-related products. As consumers grow more health-conscious, there is a significant rise in the demand for functional foods and dietary supplements that offer targeted health benefits.

Moreover, key players in the industry product launches and key developments that would drive this market growth. For instance, in August 2023, Nikko Chemicals launched Nikkol Lecinol MFL, a product aimed at enhancing the skin's barrier function by stimulating the production of ceramides and filaggrin. This ingredient is rich in lysophosphatidic acid, a type of lysolecithin known for its extensive efficacy on epidermal cells.

Increasing Number of Drug Formulations

As drug development continues to advance, lysolecithin is gaining popularity for its properties as an emulsifier, solubilizer and stabilizer, which are crucial in enhancing the effectiveness of drug delivery systems. The pharmaceutical industry is constantly developing new formulations that require improved bioavailability, controlled release and enhanced absorption of active ingredients.

Lysolecithin, being a natural phospholipid, is used to improve the solubility of hydrophobic drugs, making it a preferred choice in various drug formulations. Its ability to form liposomes and stabilize emulsions enhances the delivery and absorption of medications, which is particularly important in oral, topical and injectable drug applications.

As the demand for more complex drug formulations rises in the pharmaceutical market, the need for functional ingredients like lysolecithin increases. Furthermore, the trend toward personalized medicine, which often involves specialized drug delivery systems, is expected to boost the use of lysolecithin in the market. Pharmaceutical companies are leveraging lysolecithin to create more effective and patient-friendly drug products, thereby driving the global lysolecithin market's growth.

Availability of Cheaper Synthetic Emulsifiers

Synthetic emulsifiers such as polysorbates, mono- and diglycerides and others are widely available at lower costs compared to natural alternatives like lysolecithin. These synthetic emulsifiers often provide similar functional benefits, such as improving texture, stability and shelf life in food, cosmetic and pharmaceutical products. As a result, manufacturers seeking to reduce costs are inclined to choose these lower-priced options over lysolecithin, especially in price-sensitive markets like processed foods and mass-market personal care products.

Additionally, the production of synthetic emulsifiers tends to be more scalable and less affected by the agricultural supply chain, which often impacts the availability and pricing of natural lysolecithin. This further solidifies the position of synthetic emulsifiers in the market, as they can be produced at a consistent quality and quantity, giving them an edge over their natural counterparts.

Segment Analysis

The global lysolecithin market is segmented based on source, type, form, application, end-user and region.

Diverse Applications and Various Health Benefits of Soy

Soy lysolecithin has become a widely used emulsifier in various food products due to its ability to enhance texture, stability and shelf life. It plays a vital role across various sectors, including food, pharmaceuticals and cosmetics. With consumers increasingly favoring healthier and more natural products, the demand for soy lysolecithin is anticipated to keep rising, growing because of its diverse applications and various health benefits. This trend creates substantial opportunities for manufacturers and suppliers in the lysolecithin market.

Soy lysolecithin is being explored for its potential use in drug delivery systems. Its distinctive characteristics allow it to serve as an effective medium for encapsulating active pharmaceutical ingredients, thereby improving their bioavailability and therapeutic effectiveness. Moreover, key players in the industry introduce various products in multiple sectors and key developments that would propel this segment's growth in the market.

For instance, in January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.

Lysolecithin is an enzymatically modified form of lecithin, where a fatty acid has been removed through enzymatic processing. This modification results in a product with enhanced properties compared to regular lecithin. Similarly, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Geographical Penetration

Expansion of the Food Processing Industry in Asia-Pacific

The increasing consumer preference for natural and non-GMO ingredients in food products is a prominent trend, especially in countries like India and China. As consumers in these regions become more health-conscious, they actively seek products that align with their dietary choices. Lysolecithin, which is derived from soy lecithin, fulfills these demands as it is viewed as a healthier alternative to synthetic emulsifiers.

The rapid expansion of the food processing industry in the Asia-Pacific region is a major factor driving the demand for lysolecithin as an emulsifier. Lysolecithin is extensively utilized in various food products, including baked goods, dairy items and convenience foods. The increasing consumption of processed and ready-to-eat meals, fueled by changing lifestyles and urbanization, has further heightened the need for effective emulsifiers like lysolecithin.

As urbanization progresses and consumer habits shift towards more convenient food options, the role of lysolecithin in food formulations is expected to grow, catering to both manufacturers' requirements and consumers' desires for high-quality processed foods. There is a rising awareness of the health advantages associated with lysolecithin, such as its capacity to improve cognitive function, lower cholesterol levels and support liver health helps to propel this market growth in this region.

Key player strategies such as partnerships & collaborations and technological advancements would drive this market growth. For instance, Prathista Industries has introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.

Competitive Landscape

Bifurcation of how emerging players and startups function in the market

Emerging players and startups play a crucial role in the evolving lysolecithin market. While established players dominate large portions of the market, newer entrants are bringing innovation, agility and unique business models that challenge traditional supply chains. Many startups work closely with academic or research institutions to leverage the latest technological advancements in enzymatic processing or sustainable production methods. By adopting cutting-edge processes, they can produce high-quality lysolecithin at lower costs or with enhanced functionality, giving them a competitive advantage.

Market Presence: While startups are only entering the market, emerging players have made a name for themselves with their current offerings.

Resources: While startups frequently work with a small amount of cash, emerging players usually have access to additional resources, such as supply chains and finance.

Innovation Focus: While emerging players expand on previously developed ideas, Startups are catering to the growing demand for plant-based foods, positioning their lysolecithin products as natural emulsifiers in plant-based meat, dairy alternatives and clean-label processed foods. These companies are branding themselves as enablers of sustainable, ethical food production.

Brand Recognition: While startups are still developing their reputation and recognition in the industry, emerging players already have a certain amount of brand awareness. Startups use digital platforms to build their brand identity, often focusing on ethical sourcing, sustainability and transparency.

The major global players in the market include Kemin Industries, Inc., Cargill, Inc., Lipoid GmbH, Sternchemie GmbH & Co. KG, Alexmo Cosmetics, Cayman Chemical, Creative Biolabs, GlpBio Technology, Larodan AB and Biosynth Ltd.

Aim of trial: The objectives of this study were to evaluate three different strategies of LYSO supplementation on feedlot performance, carcass characteristics, nutrient digestion and the longissimus fatty acid profile of Bos indicus and Bos indicus crosses and to validate an innovative environmental index named InComfort (InCl) as a tool to evaluate DMI during natural heat stress events in the course of conducting open dry-lot feedlot experiments.

Materials and methods: All procedures and protocols involving the use of animals were approved by the Ethics Committee on animal use of the Sao Paulo State University "Julio de Mesquita Filho" (UNESP; Protocol number: 016339/19).

Results: In experiment (1), no differences were detected for IBW (P = 0.791). The use of LYSO increased FBW (P = 0.022); however, no differences were detected among the LYSO phase-feeding treatments (P = 0.191). Conversely, a tendency was observed (P = 0.060) when NON was compared with the pairwise comparisons of the means (GRO). In experiment (2), a treatment X breed interaction was observed, in which CEA animals had a higher IBW (P < 0.001; 406.42 vs. 372.55 for CEA and NEL, respectively); however, no differences were detected for FBW (P = 0.223; data not shown). Moreover, NEL animals from FIN also had greater DMI (P < 0.05) than NON, GRO and ALL cohorts within the same genotype but did not differ from CEA in the ALL and GRO protocols.

Conclusion: Overall, feeding LYSO during growing period (GRO) and finishing period (FIN) enhanced feedlot performance and should lead to higher intakes during very hot days of the finishing feeding period.

Consumer Analysis

Consumer analysis in the lysolecithin market helps to understand the behavior, preferences and needs of the market's various consumer segments. This analysis focuses on identifying the main industries and end-users of lysolecithin, their purchasing drivers, key concerns and the factors influencing their decision-making processes.

Consumers, particularly in the food, cosmetics and nutraceutical industries, increasingly prefer products that are natural, minimally processed and free from artificial additives. Lysolecithin, derived from natural sources like soybeans and sunflower seeds, aligns well with this trend. Although lysolecithin is favored for its natural properties, price remains a critical factor, particularly for large-scale users in the food and feed industries. Fluctuations in the prices of raw materials can significantly impact consumer purchasing decisions.

Sustainability Analysis

Sustainability is becoming a central focus for companies operating in the lysolecithin market. As industries worldwide move toward environmentally responsible practices, the lysolecithin market is being shaped by efforts to address environmental, social and governance factors. Sustainability in this market encompasses several areas, such as responsible sourcing of raw materials, eco-friendly production processes, reducing carbon footprints and offering products that align with consumer demand for clean-label, natural ingredients.

Cargill has been working to end deforestation related to soy production for more than 20 years. They promote sustainable practices to meet the world's growing demand for soy in food, animal feed and biofuels driven by increasing nutritional needs, changing dietary habits and desire for fossil-fuel alternatives. Cargill's role in the soy supply chain comes with significant responsibility and they are keenly aware of the need to deliver customer solutions in a safe, responsible and sustainable way.

By Source

  • Plant Based
    • Soy
    • Sunflower
    • Rapeseed (Canola)
  • Animal Based
    • Guinea Pig
    • Bovine

By Type

  • Hydrolyzed Lysolecithin
    • Fluid Hydrolyzed
    • De-oiled Hydrolyzed
  • Chemically Modified Lysolecithin
  • Others

By Form

  • Powder
  • Liquid
  • Granules

By Application

  • Confectionery
  • Bakery
  • Food Supplements
  • Animal Feed
  • Dairy Products
  • Personal Care and Cosmetics
  • Plant Based Alternatives
  • Others

By End-User

  • Food and Beverage
  • Pharmaceuticals
  • Cosmetics
  • Nutraceuticals

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.
  • In 2023, Prathista Industries introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.
  • In July 2022, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Why Purchase the Report?

  • To visualize the global lysolecithin market segmentation based on source, type, form, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the global lysolecithin market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Lysolecithin market report would provide approximately 78 tables, 77 figures and 215 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Consumer Awareness of Health Benefits
      • 4.1.1.2. Increasing Number of Drug Formulations
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of Cheaper Synthetic Emulsifiers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. SWOT Analysis
  • 5.6. Supply Chain Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Import and Export Analysis
  • 5.9. Clinical Trial Analysis
  • 5.10. Consumer Analysis
  • 5.11. Sustainability Analysis
  • 5.12. Heat Maps
  • 5.13. B2B Analysis

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Plant Based*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Soy
    • 6.2.4. Sunflower
    • 6.2.5. Rapeseed (Canola)
  • 6.3. Animal Based
    • 6.3.1. Guinea Pig
    • 6.3.2. Bovine

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Hydrolyzed Lysolecithin*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Fluid Hydrolyzed
    • 7.2.4. De-oiled Hydrolyzed
  • 7.3. Chemically Modified Lysolecithin
  • 7.4. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Powder*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid
  • 8.4. Granules

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Confectionery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bakery
  • 9.4. Food Supplements
  • 9.5. Animal Feed
  • 9.6. Dairy Products
  • 9.7. Personal Care and Cosmetics
  • 9.8. Plant Based Alternatives
  • 9.9. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Food and Beverage*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pharmaceuticals
  • 10.4. Cosmetics
  • 10.5. Nutraceuticals

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. US
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. UK
      • 11.3.8.3. France
      • 11.3.8.4. Italy
      • 11.3.8.5. Spain
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. Australia
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Kemin Industries, Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Cargill, Inc.
  • 13.3. Lipoid GmbH
  • 13.4. Sternchemie GmbH & Co. KG
  • 13.5. Alexmo Cosmetics
  • 13.6. Cayman Chemical
  • 13.7. Creative Biolabs
  • 13.8. GlpBio Technology
  • 13.9. Larodan AB
  • 13.10. Biosynth Ltd

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us